XL‐Protein Launches Spin-Off Pasylanta Therapeutics To Develop Long‐Acting IL‐1Ra Biobetters

(MENAFN - GlobeNewsWire - Nasdaq) Freising, Germany, May 28, 2026 (GLOBE NEWSWIRE) -- XL-protein GmbH today announced the launch of PASylANTA Therapeutics GmbH, a new Germany-based biotechnology ...